List of Excipients in API melphalan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing melphalan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | CROSPOVIDONE | |
| ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | HYPROMELLOSE | |
| ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | MAGNESIUM STEARATE | |
| ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | MICROCRYSTALLINE CELLULOSE | |
| ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | POLYETHYLENE GLYCOL 400 | |
| ApoPharma USA Inc | ALKERAN | melphalan | 52609-0001 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Showing 1 to 6 of 6 entries
Excipients in ANDA-approved (generic) drugs containing melphalan
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 | CELLULOSE, MICROCRYSTALLINE |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 | CROSPOVIDONE |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 | HYPROMELLOSE |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 | MAGNESIUM STEARATE |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 | POLYETHYLENE GLYCOL |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 | SILICON DIOXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Showing 1 to 6 of 6 entries
Detailed excipient profiles for melphalan
Excipient focus: BETADEX
melphalan drug variants containing BETADEX
| Company | Ingredient | NDC |
|---|---|---|
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
melphalan drug variants not containing BETADEX
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM
melphalan drug variants containing BETADEX SULFOBUTYL ETHER SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
melphalan drug variants not containing BETADEX SULFOBUTYL ETHER SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Excipient focus: CELLULOSE, MICROCRYSTALLINE
melphalan drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
melphalan drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Excipient focus: CROSPOVIDONE
melphalan drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
melphalan drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: HYPROMELLOSE
melphalan drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
melphalan drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: MAGNESIUM STEARATE
melphalan drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
melphalan drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: MICROCRYSTALLINE CELLULOSE
melphalan drug variants containing MICROCRYSTALLINE CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
melphalan drug variants not containing MICROCRYSTALLINE CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Excipient focus: MONOTHIOGLYCEROL
melphalan drug variants containing MONOTHIOGLYCEROL
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
melphalan drug variants not containing MONOTHIOGLYCEROL
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Excipient focus: POLYETHYLENE GLYCOL
melphalan drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
melphalan drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Excipient focus: POLYETHYLENE GLYCOL 400
melphalan drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
melphalan drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Excipient focus: PROPYLENE GLYCOL
melphalan drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
melphalan drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Excipient focus: SILICON DIOXIDE
melphalan drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
melphalan drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: TITANIUM DIOXIDE
melphalan drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
melphalan drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: WATER
melphalan drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | melphalan hcl | 60505-6414 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
melphalan drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| ApoPharma USA Inc | melphalan | 52609-0001 |
| Acrotech Biopharma LLC | melphalan | 68152-109 |
| Acrotech Biopharma Inc | melphalan | 72893-001 |
| Alvogen Inc | melphalan usp, 2 mg | 47781-200 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
